By continuing to use the site you agree to our Privacy & Cookies policy

Your browser seems to have cookies disabled. For the best experience of this website, please enable cookies in your browser.


Your browser is no longer supported

For the best possible experience using our website we recommend you upgrade to a newer version or another browser.


Haematology Nursing

News and practice for haematology nurse specialists

NICE backs drug for rare life-threatening blood disorder

NICE backs drug for rare life-threatening blood disorder


The National Institute for Health and Care Excellence has recommended eculizumab (Soliris) for treating a rare life-threatening blood disorder called atypical Haemolytic Uraemic Syndrome (aHUS).

Blood pathology

NICE backs new drug for preventing potentially fatal blood clots


The National Institute for Health and Care Excellence has approved the anti-clotting drug dabigatran (Pradaxa) as an option for treating and preventing deep vein thrombosis and pulmonary embolism.

Comments (1)

more news

RSS feed for Latest research: haematology

Latest research: haematology

Applying the correct procedures when caring for wounds is key to reducing HCAIs

Standardising aseptic technique to avoid HCAIs Subscription Required

Standardised aseptic technique training has improved nurses’ ability to prevent healthcare-associated infections in one hospital and led to better awareness of AT.

Dosette boxes can help people with memory problems self manage diabetes

Managing diabetes in people with dementia Subscription Required

The number of patients with both type 2 diabetes and dementia is rising, which poses new challenges in blood glucose monitoring and medicines administration.

search the archive

Fran Entwistle_NT

Voluntary services should supplement care, not replace it


It was not a big surprise to me to read that mental health budgets have fallen by 8% in real terms during the term of this government.

Comments (2)

Statins could be targeted to the highest-risk individuals

Gene testing could find those who would benefit most from statins

“Patients with the highest genetic risk of suffering a heart attack benefit the most from cholesterol-lowering statin drugs,” The Guardian reports.